Pfizer

Latest Pfizer Items
  • FDA says Pfizer's Prevnar vaccine works in adults

    Federal health scientists say Pfizer's best-selling vaccine, Prevnar 13, is at least as effective as rival Merck's at helping prevent sometimes deadly infections in adults.


  • Economy Briefs

    Pfizer Inc.'s just-approved Xalkori, the first new medicine in several years for deadly lung cancer, shows the value of a new research standard: precisely targeting rare diseases linked to gene variants.


  • FDA approves gene-targeting lung cancer drug

    The Food and Drug Administration has approved a new Pfizer drug for a subset of lung cancer patients with a particular genetic mutation.


  • Pfizer begins payouts in fatal Nigeria drug study

    Drug maker Pfizer Inc. says it has begun paying victims and their families affected by its fatal 1996 meningitis study in northern Nigeria.


  • Report says Pfizer may try to market OTC Lipitor

    Pfizer Inc. on Wednesday declined to comment on reports it hopes to start marketing an over-the-counter version of its cholesterol drug Lipitor, the world's biggest-selling prescription drug, after the original version loses patent protection in November.


  • Generics advancing on lucrative pet drug market

    When Samantha Lowe's 12-year-old Labrador retriever needed anti-inflammatories to ease her arthritis, she found herself facing the same question humans face when it comes to prescriptions: Name-brand drug, or generic?


  • Study: Pfizer lung cancer pill may double survival

    A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according to research presented Sunday.


  • Hormone-blocking drug reduces breast cancer risk

    Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have curbed enthusiasm for other prevention drugs, a major study found.


  • Study: Pfizer drug lowers risk of breast cancer

    Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects that have curbed enthusiasm for other prevention drugs, a major study found.


Happening Now